Metagenomi, Inc.Metagenomi, Inc.Metagenomi, Inc.

Metagenomi, Inc.

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.77USD
Revenue estimate
‪8.10 M‬USD
Market capitalization
‪282.17 M‬USD
‪−68.26 M‬USD
‪44.76 M‬USD
‪18.91 M‬
Beta (1Y)
4.72

About Metagenomi, Inc.

CEO
Brian C. Thomas
Headquarters
Emeryville
Employees (FY)
236
Founded
2016
FIGI
BBG00Y5ZXS77
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MGX is 7.53 USD — it has increased by 11.72% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Metagenomi, Inc. stocks are traded under the ticker MGX.
Metagenomi, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
MGX stock is 15.45% volatile and has beta coefficient of 4.72. Check out the list of the most volatile stocks — is Metagenomi, Inc. there?
Yes, you can track Metagenomi, Inc. financials in yearly and quarterly reports right on TradingView.
MGX stock has fallen by 1.83% compared to the previous week, the month change is a 32.71% fall, over the last year Metagenomi, Inc. has showed a 26.54% decrease.
MGX net income for the last quarter is ‪−19.29 M‬ USD, while the quarter before that showed ‪−19.82 M‬ USD of net income which accounts for 2.65% change. Track more Metagenomi, Inc. financial stats to get the full picture.
Today Metagenomi, Inc. has the market capitalization of ‪282.17 M‬, it has decreased by 19.23% over the last week.
No, MGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Metagenomi, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MGX reached its all-time high on Feb 15, 2024 with the price of 12.74 USD, and its all-time low was 6.50 USD and was reached on Apr 19, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 28, 2024, the company has 236.00 employees. See our rating of the largest employees — is Metagenomi, Inc. on this list?
We've gathered analysts' opinions on Metagenomi, Inc. future price: according to them, MGX price has a max estimate of 25.00 USD and a min estimate of 16.00 USD. Read a more detailed Metagenomi, Inc. forecast: see what analysts think of Metagenomi, Inc. and suggest that you do with its stocks.